HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of reperfusion therapy and cardiovascular drugs in the treatment of 146 men and 54 women with ST-segment elevation myocardial infarction at a University Medical Center.

Abstract
We investigated the treatment of 146 men, mean age 62 years, and 54 women, mean age 69 years, with acute ST-segment elevation myocardial infarction (STEMI) in a university medical center. Coronary revascularization or thrombolytic therapy was given to 143 men (98%) and 52 women (96%) [P = not significant (NS)]. Antiplatelet therapy and antithrombotic therapy were given to 146 men (100%) and 54 women (100%) (P = NS). Beta-blockers were given to 133 men (91%) and 45 women (83%) (P = NS). Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers were given to 122 men (84%) and 42 women (78%) (P = NS). Statins were given to 128 men (88%) and 43 women (80%) (P = NS). Nitrates were given to 94 men (64%) and 36 women (67%) (P = NS). Diuretics were given to 97 men (66%) and 37 women (69%) (P = NS). Calcium channel blockers were given to 26 men (18%) and 12 women (22%) (P = NS). There was no significant difference in the treatment of men versus women with acute STEMI.
AuthorsRishi Sukhija, Wilbert S Aronow, Devraj Nayak, John A McClung, Craig E Monsen, Robert N Belkin
JournalAmerican journal of therapeutics (Am J Ther) 2005 May-Jun Vol. 12 Issue 3 Pg. 277-80 ISSN: 1075-2765 [Print] United States
PMID15891275 (Publication Type: Journal Article)
Chemical References
  • Cardiovascular Agents
Topics
  • Aged
  • Cardiovascular Agents (administration & dosage, therapeutic use)
  • Diabetes Complications (drug therapy)
  • Drug Utilization
  • Female
  • Guideline Adherence
  • Hospitals, University
  • Humans
  • Hypercholesterolemia (complications, drug therapy)
  • Hypertension (complications, drug therapy)
  • Male
  • Middle Aged
  • Myocardial Infarction (complications, drug therapy, surgery)
  • Myocardial Reperfusion
  • Myocardial Revascularization
  • Practice Guidelines as Topic
  • Thrombolytic Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: